Prevalence of dyslipidemias in Mexico city and Its relation to other cardiovascular risk factors. Results from the CARMELA study

被引:0
作者
Escobedo-de la Pena, Jorge [1 ]
de Jesus-Perez, Ramon [1 ]
Schargrodsky, Herman [2 ]
Champagne, Beatriz [3 ]
机构
[1] Hosp Reg 1 Carlos MacGregor Sanchez Navarro, Inst Mexicano Seguro Social, Unidad Invest Epidemiol Clin Gabriel Mancere, Mexico City, DF, Mexico
[2] Hosp Italiano Buenos Aires, Dept Cardiol, Buenos Aires, DF, Argentina
[3] Fdn InterAmer Corazon, Dallas, TX USA
来源
GACETA MEDICA DE MEXICO | 2014年 / 150卷 / 02期
关键词
Dyslipidemia; Cholesterol; High-density lipoprotein; HDL-C; Low-density lipoprotein; LDL-C; Triglyceride; Prevalence; DENSITY-LIPOPROTEIN CHOLESTEROL; TREATMENT PANEL-III; MIXED HYPERLIPIDEMIA; DISEASE; TRENDS; TRIALS; METAANALYSIS; PREVENTION; PREDICTION; EFFICACY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To estimate the prevalence of dyslipidemias in Mexico city and its relation to other cardiovascular risk factors. Methods: A cross sectional study was conducted to measure cardiovascular risk factors in Mexico City. All subjects were interviewed and anthropometric measures performed, as well as cholesterol, high-density lipoproteins (HDL-C) and triglycerides. Low-density lipoprotein (LDL-C) values were calculated. Means-as well as dyslipidemia-weighted prevalence were measured, with 95% confidence intervals. Results: 833 males and 889 females were studied. The prevalence of cholesterol >= 240 mg/dl was 16.4% (95% CI: 14.2-18.7), and 34.1% (95% CI: 31.6-36.5) had values between 200 and 240 mg/dl. Very high values of triglycerides were seen in 2.6% of studied subjects and 29.9% (95% CI: 26.9-32.8) had high values. The prevalence of hypertriglyceridemia was higher in males (43.3%) than females (23%). Mean values of assessed parameters were in general higher in those with other cardiovascular risk factors. Conclusions: Lipid values in the population of Mexico City are high and so is the prevalence of dyslipidemias. There is an urgent need to implement health policies directed to diminish cardiovascular risk factors, mainly dyslipidemias.
引用
收藏
页码:128 / 136
页数:9
相关论文
共 50 条
  • [21] Prevalence of cardiovascular risk factors in South Korean adults: Results from the Korea Medical Insurance Corporation (KMIC) study
    Jee, SH
    Appel, LJ
    Suh, I
    Whelton, PK
    Kim, IS
    ANNALS OF EPIDEMIOLOGY, 1998, 8 (01) : 14 - 21
  • [22] Prevalence of abdominal aortic aneurysms and its relation with cardiovascular risk stratification: protocol of the Risk of Cardiovascular diseases and abdominal aortic Aneurysm in Varese (RoCAV) population based study
    Gianfagna, F.
    Veronesi, G.
    Bertu, L.
    Tozzi, M.
    Tarallo, A.
    Ferrario, M. M.
    Castelli, P.
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [23] Risk Factors for Venous Thromboembolism Results From the Copenhagen City Heart Study
    Holst, Anders G.
    Jensen, Gorm
    Prescott, Eva
    CIRCULATION, 2010, 121 (17) : 1896 - 1903
  • [24] Prevalence of cardiovascular risk factors and cardiovascular prevention quality in primary healthcare in Russia and European countries: EURIKA Study results
    Boytsov, S. A.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2012, 11 (01): : 11 - 16
  • [25] Low Physical Activity and Its Association with Diabetes and Other Cardiovascular Risk Factors: A Nationwide, Population-Based Study
    Brugnara, Laura
    Murillo, Serafin
    Novials, Anna
    Rojo-Martinez, Gemma
    Soriguer, Federico
    Goday, Albert
    Calle-Pascual, Alfonso
    Castano, Luis
    Gaztambide, Sonia
    Valdes, Sergio
    Franch, Josep
    Castell, Conxa
    Vendrell, Joan
    Casamitjana, Roser
    Bosch-Comas, Anna
    Bordiu, Elena
    Carmena, Rafael
    Catala, Miguel
    Delgado, Elias
    Girbes, Juan
    Lopez-Alba, Alfonso
    Teresa Martinez-Larrad, Maria
    Menendez, Edelmiro
    Mora-Peces, Inmaculada
    Pascual-Manich, Gemma
    Serrano-Rios, Manuel
    Gomis, Ramon
    Ortega, Emilio
    PLOS ONE, 2016, 11 (08):
  • [26] Prevalence and 5-year incidence rate of dyslipidemia and its association with other coronary artery disease risk factors in Iran: Results of the Kerman coronary artery disease risk factors study (Phase 2)
    Najafipour, Hamid
    Yousefzadeh, Gholamreza
    Baneshi, MohammadReza
    Gohari, Milad Ahmadi
    Shahouzehi, Beydolah
    Farokhi, MitraShadkam
    Mirzazadeh, Ali
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2021, 26 (01):
  • [27] Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen City Heart Study
    Bussink, Barbara E.
    Holst, Anders G.
    Jespersen, Lasse
    Deckers, Jaap W.
    Jensen, Gorm B.
    Prescott, Eva
    EUROPEAN HEART JOURNAL, 2013, 34 (02) : 138 - 146
  • [28] Plasma linoleic acid levels and cardiovascular risk factors: results from the Norwegian ACE 1950 Study
    Chandra, Anupam
    Rosjo, Helge
    Svensson, My
    Vigen, Thea
    Ihle-Hansen, Hakon
    Orstad, Eivind Bjorkan
    Ronning, Ole Morten
    Lyngbakken, Magnus Nakrem
    Nygard, Stale
    Berge, Trygve
    Schmidt, Erik Berg
    Omland, Torbjorn
    Tveit, Arnljot
    Eide, Ivar Anders
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2020, 74 (12) : 1707 - 1717
  • [29] The prevalence of major cardiovascular risk factors in a rural population of the Chui region of Kyrgyzstan: The results of an epidemiological study
    Polupanov, Andrey G.
    Khalmatov, Abdimetalip N.
    Altymysheva, Aliina T.
    Lunegova, Olga S.
    Mirrakhimov, Aibek E.
    Sabirov, Ibragim S.
    Kontsevaya, Anna, V
    Dzhumagulova, Ainagul S.
    Mirrakhimov, Erkin M.
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 24 (03) : 183 - 191
  • [30] Prevalence of Cardiovascular Risk Factors in Middle-Aged Lithuanian Men Based on Body Mass Index and Waist Circumference Group Results from the 2006-2016 Lithuanian High Cardiovascular Risk Prevention Program
    Rinkuniene, Egidija
    Petrulionyte, Emilija
    Dzenkeviciute, Vilma
    Petrulioniene, Zaneta
    Senulyte, Auguste
    Puronaite, Roma
    Laucevicius, Aleksandras
    MEDICINA-LITHUANIA, 2022, 58 (12):